Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest ...

Isothermal nucleic acid amplification technology market was valued at US$ 6.06 billion in 2024 and is projected to hit the market valuation of US$ 17.26 billion by 2033 at a CAGR of 12.34% during the ...

The RSC Nucleic Acids Group invites you to their Forum meeting, which will take place in-person at the RSC's iconic Burlington House in London. This is the NAG’s annual meeting, bringing together the ...

Nucleic-acid therapeutics articles from across Nature Portfolio Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides ...

Scientists at The Wistar Institute have discovered how a key protein from the Epstein-Barr virus (EBV), EBNA-LP, ...

CRISPR-based gene editing holds great promise, but off-target effects remain a major concern, especially across diverse ...

Infomercial channels are riddled with the next-best hair-loss solution, but those toupees, ointments, and hair plugs might ...

Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...